534558 Ibrance® Capsule Commercial Process: Designed for Robustness

Mary T. am Ende, Worldwide Research and Development, Pfizer Inc., Groton, CT, John Kresevic, Drug Product Design, Pfizer, Inc., Groton, CT, Matthew P. Mullarney, Drug Product Design, Pfizer Inc., Groton, CT, Holger Schlack, GTS Solid Oral Dose PPD, Pfizer, Freiburg, Germany and William R. Ketterhagen, DPD Process Engineering Sciences, AbbVie, North Chicago, IL
See more of this Session: Application of Process Modelling to Pharmaceutical Process Design and Scale-up
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum